CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍClinical Trial Agreement • March 3rd, 2020
Contract Type FiledMarch 3rd, 2020ABBREVIATED PRIVACY AND DATA PROTECTION ADDENDUM THIS CLINICAL TRIAL AGREEMENT (“Agreement”) is madeBETWEEN: Allergan Limited, a company registered in England & Wales (registered company number 1049760) whose registered office is at Ground Floor Marlow International, Parkway, Marlow, Buckinghamshire, SL7 1YL, United Kingdom (hereinafter referred to as the “Sponsor”); and Krajská zdravotní, a.s. with registered office and a place of business at Sociální péče 3316/12A, 401 13, Ústí nad Labem, Czech Republic, VAT No: CZ25488627 (hereinafter referred to as the “Institution”). Each referred to as a “Party” and together as the “Parties”. WHEREAS: A. The Sponsor is engaged in research and development of pharmaceutical products. B. The Sponsor wishes to engage the Institution to carry out the research program as set out in the Clinical Trial Exhibit. C. The Parties wish to document the terms and conditions of such engagement in the manner set out below. TATO SMLOUVA O KLINICKÉM HODNOCENÍ (